Previously, Jay spent ten years at Myriad Genetics Inc., most recently as Senior Vice President responsible for company-wide intellectual property, and was involved in R&D, marketing and business development. Prior to Myriad, Jay was a patent attorney at Alston & Bird LLP, and worked in R&D at Merck & Co., Inc. He was a co-founder of Niiki Pharma Inc., a US-based startup oncology drug development company. Jay graduated with J.D. from the University of North Carolina School of Law, M.S. in biochemistry and molecular biology from Northwestern University in Evanston, Illinois, and B.S. in genetics from Fudan University in China.
For the last 10 years Rich has been working as a commercial consultant helping companies from outside Europe access the lucrative CE market. Across a range of
clinical disciplines, he has successfully launched more than 10 novel point of care products across Europe and beyond. Rich brings a wealth of experience in both women’s health and point of care diagnostics and successful
establishment of indirect sales channels to maximise rapid market penetration. His successful network of niche IVD distributors have generated millions of dollars in sales over the years.
Rich graduated from Brunel University, West London with a BSc Hons in Medicinal, Agricultural and Environmental Chemistry.
Before Cerca Biotech, Vinicio held multiple positions in Clinical and Marketing at large pharmaceutical (Sigma Tau, Glaxo) and medical device companies. These include role as Marketing
Manager and Clinical Consultant at Biosite (then acquired by Inverness Medical, Alere and Abbot) providing leadership to the clinical support for the portfolio of products in Acute Coronary Syndrome (ACS) and in the Heart
Failure and as a clinical team member for the BNP launch in EMEA and for the Stroke biomarkers Point of Care Test.
Always interested in new and promising biomarkers, he was also involved with Critical Diagnostic in the European market launch for the ST2 cardiac biomarker.
With Myriad Genetics Inc he worked on prognostic and predictive biomarkers in breast cancer, he led the International Team for the Endopredict (Sividon Diagnostic GmbH) launch in EMEA, gaining significant experience in
breast cancer.
Vinicio graduated with a M.Sc. (Biology, Biochemistry and Cellular Bioenergetic) from the University of Padua.
Fast forward nearly 25 years, and Lucy has spent her career in the commercial world of diagnostic testing for both professional lab tests and over the counter home testing products.Lucy has an extensive and successful track record having held leadership and people management roles in Marketing, Product Management, Technical Marketing and Medical Affairs for Unilever, Abbott and LumiraDx. Lucy is a Medical Diagnostics Consultant who provides her expert advice and guidance to support companies bringing new, innovative diagnostic products to market. At Cerca, Lucy is our Marketing Director driving the development of our marketing collateral and working to build our external network of medical experts to support MammaTyper in the market.
Lucy has a BSc in Biomedical Science, MSc in Medical Diagnostics and Postgraduate Diploma in Marketing from Cambridge Marketing College.